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Abstract

A milk bank is a nonprofit service that collects, screens, and processes by pasteurization
human milk that is donated by mothers not biologically related to the infant in need. Milk is then
dispensed to hospitals and private homes to babies with a prescription. A milk bank collects and
analyzes human milk, as breast milk is the ideal nutrition source and the gold standard feeding
method for infants. Breast milk significantly reduces premature babies' chance of developing
necrotizing enterocolitis (NEC) and offers gastrointestinal protection, increases immunity,
decreases the likelihood of asthma, allergies, ear infections, obesity, and respiratory ailments.
Some mothers are unable to breastfeed their own babies related to a multitude of medical
conditions, including; breast surgery, breast cancer, thyroid disease, polycystic ovarian syndrome
(PCOS), hypoplasia, medication contraindication, complicated birth, postpartum hemorrhage, or
retained placenta. For these mothers and babies, donor milk is a viable option. The use of a milk
analyzer when evaluating and processing human milk can provide better insight into the
macronutrient content of the donor sample. This process can allow for a more targeted allocation
of the sample. Providing the 23-week-old premature infant with milk that has a higher protein
count is more suitable than offering that same sample to a full-term nine-pound baby. This
quality improvement project will chronicle the initiation of an analyzer into clinical practice,
develop a replicable template for that incorporation, and follow the impact of quantified human
breast milk in the field. Through the guidance offered by the template, the long-term goal is
increased participation of milk banks in macronutrient analysis. Identification of the values
available in each sample offers a better product to families in need and has the potential to
improve health and growth rates.
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BACKGROUND
The Problem
Not all infants are fortunate enough to receive their mother's breast milk. For a multitude
of reasons, this can be a physiologic challenge or impossibility. Breast milk is universally
accepted as the ideal nutritional source and the gold standard feeding method for infants. The
scope of this problem has existed since the beginning of time. Wet nurses, throughout history,
have been used for breastfeeding another person’s child not biologically related to them.
Accessing macronutrient, content- analyzed and designating appropriate donor milk can provide
a targeted bridge to mothers and babies in need. Pasteurized Donor Human Milk (PDHM) is
breast milk that has been donated, screened, tested for disease, and pasteurized under the
protection, safety, and regulation offered by a milk bank. Breast milk contains antibodies that
protect babies from viruses and bacteria and lowers the incidence of asthma and allergies, ear
infections, respiratory illnesses, obesity, and diarrhea. The fat in breast milk enhances brain
development and aids in the healing of the intestinal tract in premature infants with
gastrointestinal diseases, including NEC (Riordan & Wambach, 2010). Many hospitals across the
United States are now introducing the prescription use of PDHM on well-baby units and in
neonatal intensive care units as an alternative to formula in mothers who wish to exclusively
breastfeed but are unable to produce enough milk. Prior to the introduction of PDHM, the only
appropriate alternative for mothers with supply issues while in the hospital was to offer formula.
The goal is always safe milk for babies. Evidence also suggests that protecting the breastfeeding
relationship in the early postpartum period extends the duration of exclusivity. Utilizing donor
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milk when there is a medical indication for supplementation is an ideal way to promote
continuation without interference. “The most positive maternal and newborn health outcomes
from exclusive breastfeeding are realized within a minimum of three months of breastfeeding
with a dose-response effect” (American Academy of Pediatrics, 2016, page 1). Additionally, the
incentive for the development of this breast milk safety project resulted from a dangerous pattern
of mothers bringing in breast milk to the hospital that was donated by other lactating family
members or had been purchased from other mothers online. These methods are dangerous as
there is no United States Food and Drug Administration (USFDA) oversight of this practice.
Milk temperature cannot be assured, and there is no proper testing for viruses and disease outside
the protection of a milk bank. Hospitals obtain the PDHM from accredited milk banks compliant
with the Human Milk Bank Association of North America (HMBANA) guidelines and
standards. Unregulated milk cannot meet the safety standards comparable to milk offered by a
human milk bank.
Current Practice
The current trend in milk banking includes the incorporation of pasteurized donor human
milk analysis to further understand macronutrient content. As of May 2021, 6 out of 31
nonprofit milk banks in North America are using human milk analyzers, HMA. There are milk
banks using other types of analyzers that have not been USFDA approved specifically for human
milk analysis. The intent of targeting analyzed donor milk is to translate evidence acquired to
guide safe and effective medical and nursing care across a variety of settings. Using a HMA
through this process will facilitate the most targeted nutrition for infants (Ray, 2014). “The
United States Food and Drug Administration (USFDA) permitted marketing of a HMA, to aid
healthcare professionals in measuring nutrients in breast milk, including the concentration of fat,
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carbohydrate, protein, total solids, and energy.” ("FDA Permits Marketing of a Diagnostic Test
to Aid in Measuring Nutrients in Breast Milk” 2018, page 1) In 2018 the USFDA provided
approval for use in Clinical Laboratory Improvement Amendments (CLIA) labs only, and in
2019 the use of a HMA was approved universally. The composition of human milk is quite
variable and having a baseline nutrient content to aid in the fortification of milk for infants is
ideal. The variability of human milk macronutrients is related to many factors such as; the
gestation of the pregnancy, the number of times per day that mother is nursing and/or expressing
milk, the time of day that milk is expressed, how long she expresses milk, and the return of
menstruation. Providers should keep in mind that additional variables such as the preparation and
handling of fresh vs. frozen milk, duration of infant feedings, and positioning of feeding syringes
during enteral feedings will also impact the delivery of macronutrients, particularly fat.
The collection and analysis of human milk occur, as breast milk is the ideal nutrition
source and the gold standard feeding method for infants. Breast milk significantly reduces
premature babies’ chances of developing NEC. The use of a milk analyzer when evaluating and
processing human milk can provide better insight into the macronutrient content of the donors’
samples. This process can allow for a more targeted pooling of the samples. The state of the
current technology now supports the decision to analyze donor milk for nutritional content. The
outcome goal post-implementation includes targeted milk for babies in need, resulting in
improved growth rates. Human milk analysis puts milk banks at the forefront of change and
progress in an industry whose goal is providing optimal care to infants. To understand human
milk analysis, it is essential to know that milk banks throughout North America deliver
pasteurized donor human milk (PDHM) to Neonatal Intensive Care Units (NICUs) and wellbaby postpartum units to babies in need. PDHM is beneficial when supplementation of mothers'
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milk becomes necessary. Using a HMA to assess the macronutrient content of pooled PDHM
can provide valuable insight, so that milk may be targeted and allocated appropriately to
individual babies based on the specifics of their gestation, growth and medical need.
Project Description
This project includes the development of a procedural template (Appendix E) that other
milk banks and NICUs can use to facilitate an easy transition from theory to practice. It accounts
this idea’s journey, change process, and experiences from the concept introduction, staff
education, incorporation, launch, and continuance. The goal of the template is to provide milk
banks considering the incorporation of a human milk analyzer into practice with a plan or layout
that makes the process uncomplicated. The template will be offered to milk banks throughout
North America and to the manufacturer’s laboratories. It will be presented to the Human Milk
Bank Association (HMBANA) standards committee. While pending approval, there will be a
poster presentation of the template at the 2022 HMBANA conference. The template
development portion of this project was conducted on a voluntary basis by the doctoral student,
and did not incur any additional expense to the milk bank. The project intended to implement a
quality improvement program to improve the understanding, acceptance and use of milk analysis
in the milk banking community. Using of a logic model, a plan was developed to demonstrate
the purpose and objectives within a timeline focusing on the identification of need, process,
planning, incorporation of the change model, and its effect on care that will lead to an
improvement in nutrition. In the form of a created brochure, poster and PowerPoint, this
template will be a guide for other milk banks to use when they incorporate milk analysis into
their clinical practice.
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Project Recipients
The primary recipients of this template will be the remaining 24 milk banks in North
America that are not using this human milk analyzer. The experience of following a milk bank
as they navigate the journey of pasteurized donor human milk analysis from inception and
purchase of the HMA to the hospital roll-out has provided a solid foundation for the template
development. During this time, this author has participated in many meetings, compiled research
articles, and become acquainted with a whole world of specialists, scientists, and academics that
have provided an all-encompassing understanding and perspective on the incorporating of a
human milk analyzer into a milk bank.
Secondarily, hospitals and NICUs will benefit from the introduction of milk analysis at
their supporting milk banks. “Milk analysis is a tool available to neonatologists and NICUs.
Colleagues in the medical, research, and milk banking community are energized about the new
evidence on the accuracy and clinical utility of the analyzers now available.” (About Us •
Mothers' Milk Bank Northeast, n.d.)
Finally, babies will benefit from this project as breast milk is the ideal nutrition source
and the infant’s gold standard feeding method. The use of a milk analyzer when evaluating and
processing human milk can provide better insight into the macronutrient content of the donor
sample with a more targeted allocation to babies. This project places value on optimal health
and nutrition for neonates using creative, scientifically advanced modalities to better understand
the macronutrient content of donor human milk. Health care providers and scientists are
accountable for developing, utilizing, and transforming the delivery of optimal nutrition to
transform the universe for families.
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Expected Result
The expected result of creating a template to guide the incorporation of a human milk
analyzer into a milk bank is a seamless transition from donor milk that has not been analyzed to
successful human milk macronutrient analysis. Secondarily, the expected result includes
improved growth rates with improved health for neonates receiving PDHM that has been
analyzed for macronutrient content. This program will facilitate stronger fortification strategies
for our NICUs.
Purpose
The purpose of chronicling the incorporation of a HMA into a milk bank practice is to
use the information and experience gained to accurately develop a template for standardization
and streamlining of the process. Human milk analysis is a relatively new endeavor in the milk
bank community, so the establishment and creating a template can provide an opportunity for
standardization following HMBANA guidelines. This process can make navigation safer, easier,
and timelier for forthcoming milk banks while reinforcing a quality outcome. The focal point
will be on human milk analysis of macronutrient content of PDHM to more specifically allocate
appropriate milk to babies. Beginning in November 2020, pooled milk was analyzed for the
purposes of machine mastery and laboratory practice. Following analysis of donor pools and
several months of practice with the HMA, the process of analyzing PDHM and producing Milk
Batch Analysis Reports (MBAR’s) will be considered the standard of care. Conscious efforts
will also be made during this process to increase the number of donors per pool in an effort to
more richly fortify the quality of the milk and provide more antibodies.
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Aim of Project
The expected result of creating a template for incorporating of a HMA into a milk bank is
to increase the ease and effort involved in analyzing milk and remove the barriers that can
present themselves while embracing a change process. Through the process of analyzing
PDHM, we are creating the opportunity for infants to receive the most optimal, appropriate,
high-energy, and nutrient-dense breast milk available to them, thereby supporting their growth.
A template can save other non-profit milk banks precious time and money. Having this guide
removes the margin of error that we encounter when developing new modalities to increase
productivity and efficiency. The Theory Logic Model will demonstrate how human milk
analysis can be a process improvement endeavor. The intention is to describe how and why
change happens on this occasion. Increased knowledge that will accompany this transition and
change process should result in more targeted, accurate behaviors and outcomes. Identification
of the program components and stakeholders will facilitate the process of creating forwardthinking change and produce insightful improvements. The outcomes' goal post-implementation
includes targeted milk for babies in need, resulting in improved health and growth rates.
Steps to Implementation
The steps to the successful implementation of the project begin with evidence-based
education in the milk banking community, specifically to the remaining milk banks in North
America not analyzing milk for the identification of macronutrient content. The forum for this
educational plan begins with dispensing information via phone calls, emails, meetings, and
presentation at the HMBANA conference in April, 2022. Formal education includes the
HMBANA presentation in PowerPoint and posters and the distribution of the created brochure
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template detailing the many steps and phases included in the incorporation of a HMA into
clinical practice.
Significance for Nursing
Creating a template to incorporate human milk analysis in milk banks is significant to
nursing primarily because it offers the opportunity for better patient care with improvements in
outcomes. Human milk analyzers can measure the macronutrient content in donor milk, thereby
allowing for the targeted allocation of the most appropriate milk. The most vulnerable neonates
receive the highest protein and fat milk. This process reduces the risk of postnatal growth
restriction while receiving breast milk, mother nature's perfect food. Long-term follow-up of
infants who receive targeted PDHM will assuredly demonstrate decreased growth restriction as a
measure of the magnitude of the successful treatment effect. This template has the capacity to
improve patient care through the positive influence of the health care provider. Its impact and
improvement on the current medical practice of offering PDHM that has not been analyzed can
be considered practical and prudent. The knowledge imparted to the nurse about caring for
infants through milk analysis with the clinical support and milk bank safety assurance of a
template advances our profession by advocating for the highest quality mothers' milk alternative.
The interventions of this project will assist nurses in promoting newborn health. This template
makes human milk analysis easier. Human milk analysis is significant to all the components of
healthcare as it improves neonatal health and growth and supports exclusive breastfeeding rates.
Improvement in exclusive breastfeeding rates can be translated into economic and healthcare
benefits at a global scale while decreasing global healthcare expenditures.
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LITERATURE REVIEW

This DNP quality improvement initiative will chronicle the incorporation of the USFDA
approved HMA into practice at a non-profit milk bank in the northeast. By chronicling the use of
the human milk analyzer, a procedural template for the use of targeted human milk will be
developed and established for other milk banks to utilize. “The milk bank’s mission is
engagement in the larger landscape of breastfeeding support, in which donor milk plays a critical
role. Staff is committed to ensuring that milk donation becomes as widely known to the public
as blood donation.” (About Us • Mothers' Milk Bank Northeast, n.d.) The current trend in milk
banking includes the incorporation of pasteurized donor human milk analysis to further
understand macronutrient content. The intent is to translate evidence acquired to guide safe and
effective targeted medical and nursing care across a variety of settings. This literature review
examines the elements, barriers, facilitators, and changes involved in the process of
incorporating the HMA into practice at a human milk bank.
When a mother is unable to feed her infant, donor milk is recommended as the best
alternative. (Radmacher & Adamkin, 2017) Human milk analysis is essential in adapting donor
milk for the fortification in preterm neonates, and mid-infrared spectroscopy is an accurate way
to measure the macronutrient content of human milk (Billard et al., 2015). Using the Human
Milk Analyzer through this process will facilitate the most targeted nutrition for infants (Ray,
2014). Biomolecules in breast milk are challenging and difficult to characterize based on their
diversity (Ninnonuevo et al., 2009). Despite this complexity, “HMA can inform health care
providers information to more closely match an infant’s diet with nutritional needs for adequate
growth and development.” (Radmacher & Adamkin, 2017, p. 34) “The HMA will improve the
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ability of human biologists and anthropologists to study human milk in field settings.” (Miller et
al., 2012, p.1)
Comparisons of human milk samples demonstrate “a significant difference in calorie
values between methods. A mean calorie difference of 3.1kcal/ ounce is clinically important for
preterm infants, suggesting the need for standardization.” (Perrin et al., 2020, p. 1692) “Preterm,
small for gestational age (SGA) HDM was significantly higher in protein, fat, and energy content
than appropriate for gestational age (AGA) HDM and significantly lower in carbohydrate content
than AGA HDM. Prematurity is an important determinant of macronutrient content in human
milk.” (Mills et al., 2019, p. 1155) “Infrared instruments may be useful tools to help milk banks
determine how to combine milk from multiple donors to achieve target fat and protein amounts.”
(Perrin et al., 2019, p. 6) Research studies have considered the possibility of formulating
concentrated human milk and freeze-drying it as an additive to milk to bridge the gap in calorie
differences between pools. (Oliveira et al., 2019) There are many elements that affect and
influence macronutrient content. Research has told us that it is crucial to ensure the proper
measurements of macronutrients in donor milk. (Kwan et al., 2020) These measurements are
crucial to neonatal growth and are not directly influenced by the infant’s gestational age.
However, it has been noted that protein count shows a tendency to decrease with the duration of
lactation. (Kreissl et al., 2016) The factors that can influence these macronutrient values are
varied. A woman’s diet is thought to directly impact the quality and carbohydrate, fat, and
protein breakdown of her milk. (Bravi et al., 2016) Milk storage containers can also be
impactful. “Our study reveals that fat loss occurred in all the breast milk samples that were
stored in the nine containers investigated. The loss of fat was as high as 9%.” (Chang et al.,
2012., p. 9) The storage and freezing of breast milk can diminish antioxidant activity. “Fresh
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human milk has the highest antioxidant capacity, which decreases with storage over time. To
preserve antioxidant capacity, milk should only be stored for a short time at refrigerator
temperature and not frozen” (Hanna, 2004, p. 519). Milk storage and freezing have also been
shown to decrease glutathione (GSH) content. GSH has the capacity to detoxify various types of
toxins and carcinogens. (Ankrah, 2000) The method of pasteurization can influence the
macronutrient quality of donor milk. Protein content has been noted higher in holder
pasteurization samples, as opposed to retort sterilization methods (Meredith-Dennis et al., 2017).
Finally, instrument accuracy and poor adherence to calibration guidelines can demonstrate
variability in values and inaccurate performance outcomes, further complicating analysis results
(Giuffrida et al., 2018). “Knowing the macronutrient content of the breast milk may help the
health care team and parents make informed decisions on how to fortify the breast milk based on
the individual needs of the infant” ("FDA Permits Marketing of a Diagnostic Test to Aid in
Measuring Nutrients in Breast Milk," 2018, p. 1).
“Milk analysis is a relatively new addition to the tools available to neonatologists and
NICUs. The state of the current technology now supports the decision to analyze our donor milk
for nutritional content” (About Us • Mothers' Milk Bank Northeast, n.d.).
THEORETICAL FRAMEWORK
For this project, the Roy Adaptation Model developed by the theorist Calista Roy was
applied. The Roy Model views humans as holistic, adaptive systems. The project goal is to
promote adjustments that support health and increase adaptability to the vulnerable states of
human babies. By the use of feedback and management plans, goals have been modified
throughout the process. The project has been able to prioritize the needs of team members and
recipients while creating a quality improvement template in an accurate, thorough, and timely
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manner. The principles and assumptions of the Roy Adaptation Model place value on human
relationships using creative abilities of awareness. People are described as accountable for
deriving, sustaining, and transforming the universe. This project places value on optimal health
and nutrition for neonates using creative, scientifically advanced modalities to better understand
the macronutrient content of donor human milk. Health care providers and scientists are
accountable for developing, utilizing, and transforming the process of the delivery of optimal
nutrition to transform the universe of these families in need. “Adaptation is the basis for the
fundamental concept of homeostasis which is widely used in the study of biology. Adaptation
relates to the way an individual responds to changes in the environment, whereas homeostasis is
concerned with the internal environment (Akinsanya, 2015, p. 13). This program places value on
the interdependence of human beings, while “deriving, sustaining and transforming” health care.
METHODOLOGY
The process of developing a project connected to breast milk was very organic based on
the author’s roles and experience as a nurse practitioner and lactation consultant. The project
approval process was initiated and readily accepted on the heels of multiple meetings with the
founding director of the milk bank. Together the author and milk bank director established the
PDHM program and Milk Depot at the local hospital. The IRB approval was waived based on
the quality improvement (QI) nature of the project and template creation. This project does not
jeopardize any violation of the Health Insurance Portability and Accountability Act (HIPPA), as
the element of concern is connected to donor breast milk and its allocation upon analysis. Donor
names are never involved in the milk distribution process. Data collection is centralized around
the process, rendering the identification of sample collections referred to as “Batch A, B, C, D,
etc.”. In the clinical practice setting, the founding director of the milk bank is credentialed to
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approve the process based on her instrumental role at this facility. She has willingly volunteered
to serve on the Scholarly Project Committee and is qualified to do so based on her extensive
expertise in this field.
Risks and Benefits
Risk analysis involves the evaluation of external opportunities relevant to the
incorporation of a human milk analyzer into a milk bank. The most significant opportunities for
this project are connected to the unique occasion to improve the quality and measurability of
PDHM, in response to new USFDA guidelines. Through macronutrient analysis, NICUs and
postpartum units will have the fortuitous opportunity to provide targeted, fortified nutrition as a
result of this machine and its incorporation into practice. Using the HMA can enhance growth
rates for babies improving their transition from the hospital to home. This project has the
opportunity to dispute the claim that “babies don't thrive on donor milk” based on precise,
factual data. Through this program, there is an opportunity to reduce the variability in nutritional
intake compared to generic fortification. It is essential to educate staff RNs about evidence-based
guidelines and thereby improve patient and family education regarding the use of analyzed
PDHM. Health care providers and families need to better understand that “Human milk analyzers
are increasingly used to rapidly measure the macronutrient content in breast milk for individual
target fortification, to reduce the risk of postnatal growth restriction.” (Kwan et al., 2020, p.
2121) Risk Analysis includes a comprehensive understanding of the threats that jeopardize the
project's success. Currently, competitors are attempting to develop more effective products as
they study the current model, its assets, and its deficits. Due to calibration inconsistencies, there
is the potential for USFDA approval to be threatened or removed based on variations in
macronutrient analysis. The HMA can provide us with a false sense of security regarding
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macronutrient values if not properly calibrated. Operational errors and maintenance errors must
always be considered as a threat. The additional cost to a human milk bank can be prohibitive to
many non-profit institutions. The final recognizable threat is that long-term studies demonstrate
no improvement in growth rates for babies receiving PDHM that has undergone milk analysis, as
the concept of using a USFDA-approved modality specific to human milk is still in the neonatal
stages.
Despite the risks, the analysis identified many important strengths. The APN compiling
this information and writing the template has expertise in breast milk, lactation, and women's
health while functioning in a clinical position at a hospital receiving and using PDHM.
Additionally, the same APN brought the concept of using donor milk in lieu of formula to the
hospital while also establishing the hospital's milk depot. A milk depot is a collection point for
milk donors to send their excess supply to milk banks. It is a strength having direct access to the
milk bank, NICUs, and postpartum units using donor milk. The project’s strength is also
evidenced by the support it has received from experts in the field who are associated with the
milk bank and invested in its success. Their support is evidenced by the many emails, insights
and perspectives, opinion contributions, phone calls, article advice, and virtual meetings. There
is a precise level of strength in being a pioneering milk bank incorporating the analyzer into
practice, on the heels of FDA approval.
This DNP quality improvement initiative will chronicle the incorporation of the USFDAapproved human milk analyzer into practice at a milk bank in the northeast. By chronicling the
use of the human milk analyzer, a procedural template for the use of targeted human milk will be
developed and established for other milk banks and neonatal intensive care units to utilize. This
initiative will be followed and developed to provide a comprehensive template or guide for other
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facilities interested in incorporating human donor milk macronutrient analysis into their clinical
practice. The development of this project includes the use of a framework to identify strengths,
weaknesses, opportunities, and threats (SWOT) to the use of a milk analyzer, and the
development of a procedural template when processing pasteurized donor human milk. The
SWOT analysis will be used by the APN and Executive Director of the milk bank throughout the
process of incorporating the HMA into the milk bank’s new guidelines and while writing the
template. Through this dynamic process, the team hopes to clearly identify the strengths at hand
while focusing on methods to minimize weakness. This project is well-aligned with the milk
bank mission of engagement in the larger landscape of breastfeeding support, with donor milk
playing a critical role. It is the hope and goal of the milk bank to ensure that milk donation
becomes as widely accepted and known to the public as blood donation.
The first step in the SWOT analysis identified many important strengths. This author has
expertise in breastmilk, lactation, and women’s health.

Additionally, the author brought the

concept of using donor milk in lieu of formula to the hospital while also establishing the
hospital's milk depot. Through this journey, a relationship was developed with the collaborating
milk bank. It is a strength having direct access to the milk bank. It is a strength having direct
access to the milk bank, NICUs, and postpartum units using donor milk.
The second step of the SWOT analysis identified several weaknesses addressing the
ethical controversy regarding the analysis of PDHM and universal concerns over a false sense of
assuredness to NICUs and postpartum units. The measurements need to be authentic and
accurate. “The HMA, based on mid-infrared methodology, is convenient for a unique
determination of macronutrients. However, HMA measurements are not totally comparable with
reference methods (RMs).” (Billard et al., 2015, p.19) The potential exists that milk analysis
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may threaten the breastfeeding model and inspire mothers to then seek to evaluate their own milk
for protein, fat, and carbohydrate content. Those results have the potential to negatively affect a
breastfeeding dyad. Donor milk that is lower in content may be devalued and discarded. The
presence of trepidation regarding the use of donor milk in some institutions exists. Milk analysis
is not a universally embraced concept and can be likened to opening a pandora's box.

There is a

lack of long-term evidence of the effectiveness of the process of human milk analysis related to
recent USFDA approval. A weakness includes the lack of universal support and understanding
by the milk bank culture.
Many knowledge deficits regarding the use of donor milk exist in hospitals and
communities. Clinical staff tends to be more receptive to donor human milk banking than nonclinical health workers who are not familiar with its use. At the same time, many communities
have never even heard of milk donation. There is an expense associated with the use of PDHM.
With a prescription and a medical indication, insurance is expected to reimburse recipients for
the cost; however, without a medical indication PDHM can average $4.50 an ounce. An expense
that can accumulate rapidly.
The third step in the SWOT analysis involves the evaluation of opportunities (external)
relevant to the incorporation of a human milk analyzer into a milk bank. The most outstanding
opportunities for this project are connected to the unique occasion to improve the quality and
measurability of PDHM, in response to new USFDA guidelines. Through macronutrient
analysis, NICUs and postpartum units will have the fortuitous opportunity to provide targeted,
fortified nutrition as a result of this machine and its incorporation into practice. Using the HMA
can enhance growth rates for babies improving their transition from the hospital to home. This
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project has the opportunity to dispute the claim that “babies don't thrive on donor milk” based on
clear, factual data.
The fourth and final step of the SWOT analysis includes a comprehensive understanding
of the threats that jeopardize the project's success. Currently, HMA competitors are attempting
to develop more effective products as they study the current model, its assets, and its deficits.
There exists the potential for FDA approval to be threatened or removed based on variations in
macronutrient analysis due to calibration inconsistencies. The final recognizable threat is that
are no long-term studies in human milk analysis, as it is a relatively new concept.
Timeline
This project implementation timeline to date starts with months one and two to include
identifying of the scholarly project topic, establishing of a mentor, thorough literature review,
further research of the topic to ensure understanding, and the creation of an annotated
bibliography. Month three to five include; weekly meetings with the mentor via phone, email,
text, zoom. There were many conversations with field experts, participation in virtual training
sessions with the lab, revision of the milk bank website position statement, development of a
charting system using an Excel spreadsheet for lab data and macronutrient content. There were
many phone calls with executive directors of various milk banks to discuss their transition to the
use of a HMA. All of this information was provided to my mentor regarding the specific
knowledge gained. The development of a SWOT analysis and risk management matrix. There
were many additional follow-up phone calls with other milk banks for procedural guidance. On
November 13, 2020, the incorporation of the HMA into the milk bank was initiated with success.
Following this official beginning, this author was tasked with selecting an appropriate related
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academic article on the calibration of a HMA, and began preparations to present it to the Board
of Directors (BOD).
Month six and seven started with the presentation of the milk analysis article to BOD. It
was well-received and many questions ensued. There was an extensive follow-up and continued
evaluation of HMA reports, including a very informative virtual meeting with nutritional experts
to understand the results of milk analysis more effectively. At this time, we had to revise the
Excel worksheet to reflect our new understanding. In an effort to improve fortification, the bank
attempts to increase donors to 3 per batch, despite barriers with lactobacillus infection rates. In
response to this, there were multiple meetings to discuss research-related articles to troubleshoot
the bacillus outbreak. Additionally, there were several meetings with the operations team to
change HMA spreadsheet. A letter was composed to inform hospital recipients of the use of
HMA and its effect on their practice and relevance to babies. Together with the milk bank
director, the Nutritional Standards Committee (NUTS) HMBANA guidelines were reviewed, and
modifications were made to the hospital letter based on the updates.
Month eight through eleven included a continued collection of data and evaluation of
MBA reports, milk pooling, and bacillus rates. Data was compiled on the projected sustainability
of the project. Using the information acquired to this point, the template is choreographed.
Month twelve takes us to the anticipated official roll-out of our HMA to hospitals and the
presentation of the template. There is a delay in the official roll-out in response to covid related
staffing deficits. The projected roll-out is established as fall 2022. A graphics company is
contracted and the develop a beautiful poster and pamphlet.
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Budget
Developing a budget imparts important questions and analysis to the agency at hand.
“Once management has decided on a business plan, they need to determine a) if they can afford
those goals b) if the plan will make a profit and c) if the plan will meet the goals set by
management” (Siciliano, 2015, p. 177). Over the course of many months, extensive discussion
and collaboration between the milk bank and their BOD led to the mutually agreed upon
establishment of a business plan that included the incorporation of a human milk analyzer into
practice.
As a non-profit, this milk bank attempted to offset the cost of an analyzer by applying for
a grant for the $50,000 project. The grant was denied as the organization offering the assistance
did not support the concept of payment for donor milk. The business plan was strategic, and the
milk bank was able to safely afford the established goals by tapping into their capital budget.
The milk bank’s proper planning and financial management provided a cushion of funds from
the revenues acquired and secured the milk analyzer. The incorporation of the HMA was never
intended to make a profit for the company. The acquisition provided an opportunity for
additional human milk research, data, and macronutrient content evidence to dispute the theory
that babies do not grow successfully on donor milk. Using an analyzer keeps the milk bank at
the forefront of change and innovation in milk banking. “The purpose of healthcare professional
education is to educate learners to a high standard and keep them up to date-not make a profit.”
(Managing a Budget in Healthcare Professional Education, n.d., p. 72) The return on investment
is anticipated to equal the upfront cost but not generate any profound change or growth in the
financial direction of this nonprofit organization. The operational budget will cover the monthly
cost associated with maintaining the human milk analyzer.
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The cost of the analyzer is $50,000, annual service and extraneous expenses averaged
approximately $7,800. (Appendix C) The expense for HMA supplies and disposables is based
on last year's processing estimates of 522,000 ounces of milk.
The chronicling of this process and the choreography of an instructional template to
guide other milk banks through the incorporation of a human milk analyzer into their practice
will not incur any additional expense to the institution, as it is a voluntary, academic endeavor.
The template is now available and offered to milk banks throughout North America. It has been
submitted to the product manufacturer laboratories and has been forwarded to the HMBANA
standards committee for their review. The template development portion of this project is on a
voluntary basis by the doctoral student, and did not incur any additional expense to the bank.
Labor hours have been spent on research, observation, education, the choreography of the
proposed template, and presentation of the finished product to interested milk banks and
HMBANA.
The budget is a planning tool. “A nonprofit budget is a planning document used to predict
expenses and allocate resources for your organization.” (Nonprofit Budgeting: Understand the
Basics, 2020, p. 1) Through strategic planning, effective allocation, and earmarking, the milk
bank was able to format a successful budget to guide their non-profit milk bank to the forefront
of change and progress in this industry. Macronutrient analysis of human milk provides targeted
milk for vulnerable neonates to enhance their growth and development and reduce their risks of
medical complications associated with prematurity.
Marketing
“As the philosophy and marketing techniques in other fields cannot find applicability in
the healthcare services, healthcare needs its own approach to present certain features that are not
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found in other industries.” (The Impact of Marketing Strategies in Healthcare systems, n.d., p.
93) Marketing a project in the confines of the milk bank, hospital dynamic is much less complex
than marketing a product in the business world to consumers. Buy-in already exists based on the
nature of the established, trusting relationships, and the mutual goal of delivering quality
healthcare.

The Human Milk Analyzer project is research-based, with an educational tool

designed to improve the process of allocation of human milk-based on its macronutrient content
and the nutritional needs of NICU babies. Marketing includes the preparation of an informative
letter notifying the participating hospital’s NICUs' of the change process, the inclusion of
estimated milk batch analysis reports with each batch of donor milk delivered, and finally an
update to the milk banks' website informing the public about the analyzer. The financials of the
marketing plan included 20 hours of time divided by three people to create materials to roll out
the program, at an average of $30 an hour for twenty hours, or $600. The key stakeholders
include; the milk bank, the participating hospitals, the recipients of the donor milk, and the
breastfeeding community at large. The critical focus of marketing is directed towards the ninety
hospitals participating in the allocation of milk from this milk bank, and the letter addressing the
change process (Appendix A) describing what it means to their patients and families. A great
deal of focus and attention was also given to the website position statement on milk analysis
(Appendix B)
Needs Assessment, Phase 1
The needs assessment for this project includes the systematic process for determining and
addressing the gaps that exist when a hospital is trying to support breastfeeding and the use of
donor milk as the current alternative condition. There exists a more accurate modality to target
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PDHM through human milk analysis that has prompted the use of an analyzer. Milk analysis
bridges the gap and provides the most allocated nutrition for babies.
The identification of a better way to provide PDHM to babies, improve their growth and
the desire to be at the forefront of progressive change in milk banking prompted this milk bank
to invest in an analyzer. The serendipitous timing of this author’s interest in a project involving
human milk banking made this an ideal and mutually beneficial collaboration.
Stakeholder Support, Phase 2
The milk bank research and the advisory board did not previously support the use of
human milk analyzers as there was not one USFDA approved. The sentiment was that cow
analyzers, being used by many milk banks, were not wholly accurate on human milk. Following
USFDA approval, the advisory board and milk bank staff were eager to partake in a venture that
could improve health and growth rates. Other stakeholders included hospitals, health care
providers, and NICUs. NICUs want an analysis of milk to account for individual variation when
fortifying donor human milk, the HMA measures that individual variation accurately. With the
hospital, providers, and the milk bank on board, stakeholder buy-in was complete.
Communication was essential in ensuring this phase and bringing human milk analysis to the
forefront of the milk bank mission.
Implementation, Phase 3
The initial implementation of the project, following the purchase of the HMA, included a
plethora of meetings with field experts familiar with the process of milk analysis; milk bank
directors using this analyzer; neonatologists, scientists, dieticians, pediatricians, nurses, and
IBCLCs. Phone calls, emails, meetings, text messages, in-services, reading, and research built a
solid foundation for the program. Following the establishment of a strong initial structure,
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training with the manufacturer began, Since the company is based in Upsala, Sweden the training
included many early mornings meetings. In these meetings, we were educated and in-serviced
on the details of operation and calibration. Other phases of the initial implementation included
the composition and revision of the milk bank position statement regarding the introduction of
human milk analysis into the distribution of PDHM to NICUs (Appendix B). This author was
responsible for writing the letter to hospital recipients (Appendix A) regarding analysis of
PDHM and its potential effect on their practice and relevance to babies in their care. Together
with the milk bank director, the NUTS guidelines were evaluated and the hospital letter was
modified based on the updates. Tireless efforts were applied to the development of a charting
system using the Excel spreadsheet for lab data, and macronutrient content including the
compilation of charting for laboratory data.
The next step included selecting an appropriate related academic article on the
calibration of a HMA, and this author began preparations to present it to the BOD. It was wellreceived and many questions ensued all connected to this endeavor. There was an extensive
follow-up and continued evaluation of HMA reports, including a very informative meeting with
an experienced dietician to understand the results of milk analysis more effectively. At this time,
we had to revise the Excel worksheet to reflect our new understanding. In an effort to improve
fortification, the bank must attempt to increase donors to 3 per batch, despite barriers with
lactobacillus infection rates. There were multiple meetings to discuss related research articles to
troubleshoot the bacillus outbreak in response to this. Additionally, there were several meetings
with the operations team to change HMA spreadsheet. On November 13, 2020, the incorporation
of the HMA into the milk bank was initiated with success.
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Ongoing Implementation, Phase 4
As the implementation and roll-out came closer to fruition, the efforts to increase
fortification by increasing pool donors to three per batch continued. This increased number of
donors is associated with high rates of bacillus in milk, thereby bringing the production of HMA
to an abrupt halt and reflexively delaying roll-out. In response to the bacillus identification, milk
is wasted. Field experts, assembly line specialists, milk scientists, and manufacturing engineers
are consulted and offer a plethora of advice and guidance.
Additionally, the milk bank sustained a great hit during the Covid-19 pandemic. Many
staff changes ensued. The director of the milk bank stepped down, the lab director, the director
of hospital relations, and many laboratory technicians resigned unable to perform their functions
in the face of the pandemic. These principal staff and directorial changes put the HMA roll-out
on the lower end of the priority list. The HMA manufacturing company was asked to return to
the bank, assist with the new staffing changes and assume responsibility for operations
orientation. During the delay in production, this author was able to reflect on the experiences of
the last year and create the template (Appendix E) for the incorporation of an HMA into practice,
as the foundation for this project had been thoroughly established by this time. Ongoing
implementation includes paying close attention to the budgeting and marketing components
throughout. The most incredible opportunities for this project are connected to the unique
occasion to improve the quality and measurability of PDHM, in response to new FDA
guidelines. “A wide variety of bacteria contaminate human milk from donor mothers” (Landers
& Upgrove, 2010, p. 121).
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Project Evaluation, Phase 5
The observational and participatory experiences can measure this project evaluation over
the past year and create a change process procedural template for the incorporating a human milk
analyzer into a milk bank. The long-term implications of the effectiveness of the template are
yet to be measured, based on the composition of this quality improvement initiative. The project
outcome can be clearly evaluated and considered in the forthcoming years, as we ascertain the
level of participation in human milk analysis and the utilization of our template as a procedural
guideline meant to augment the process. If the majority of milk banks in North America are
analyzing donor milk in one year, with success and ease, then we will consider this project and
template to be successful.
Data Collection and Analysis
The outcome measurements for data collection and analysis of this long-term study will
include the quantitative results captured to measure the change process in milk banks. How
many milk banks have incorporated the use of the template into their practice? Ascertaining the
number of banks is a simple process that does not require complex statistical analysis; however,
it will take time to be measured over the period of approximately twelve months. To enhance the
efficacy of findings and usefulness of the template, a follow-up survey has been developed to be
distributed to milk banks with the template to measure and assure that the template was obliging
(Appendix F). Additionally, a post implementation feedback survey was created for hospitals to
complete so that we may better measure the effectiveness of milk analysis from health care
providers perspectives (Appendix G).
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Conclusions and Summary
A milk bank is a non-profit service that collects, screens, and processes by pasteurization
human milk that is donated by mothers not biologically related to the infant in need. Milk is then
dispensed to hospitals and private homes to babies with a prescription. Breast milk is collected
and analyzed, as it is the ideal nutrition source and the gold standard feeding method for infants.
In January 2019, the HMA became the first USFDA-approved analyzer for use with human milk
in clinical and milk bank settings. The HMA uses mid-range infrared transmission spectroscopy
and patented innovation to analyze the macronutrients, energy, and total solids in human breast
milk. This milk bank has been utilizing the HMA to strategically pool and prepare optimal
batches of PDHM since November 2020. The analyzer is calibrated once a day and validated
every 10 samples, per the manufacturer and USFDA guidelines. The composition of human milk
is quite variable and having a baseline nutrient content to aid in the fortification of milk for
infants is ideal.
Through this process, under the guidance of the milk bank, this author has developed a
procedural template that other milk banks and NICUs can use to facilitate an easy transition from
theory to practice. The template chronicles this idea’s journey, change process, and experiences
from the concept introduction, staff education, incorporation, launch, and continuance. The goal
of the template is to provide milk banks considering the incorporation of a human milk analyzer
into practice with a plan that makes the process uncomplicated. Simplification of macronutrient
analysis enhances targeted nutrition while improving health and growth.
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APPENDICIES
Appendix A
Letter to Hospitals

In January 2019, the MIRIS Human Milk Analyzer (HMA) became the first FDA-approved
analyzer for use with human milk in clinical and milk bank settings. The MIRIS HMA uses midrange infrared transmission spectroscopy and a patented innovation to analyze the
macronutrients, energy, and total solids in human breast milk. Mothers’ Milk Bank Northeast
has been utilizing the MIRIS HMA to strategically pool and prepare optimal batches of
pasteurized donor human milk (PDHM) for the last 3 months. The analyzer is calibrated once a
day and validated every 10 samples at MMBNE, per the manufacturer and FDA guidelines.
The composition of human milk (donor or mother’s own milk) is quite variable and having a
baseline nutrient content to aid in the fortification of milk for infants is ideal. The variability of
human milk macronutrients is related to many factors such as the gestation of the pregnancy,
the number of times per day that mother is nursing and/or expressing milk, the time of day that
milk is expressed, how long she expresses milk, and the return of menstruation. Providers
should keep in mind that additional variables such as the preparation and handling of fresh vs.
frozen milk, duration of infant feedings (bolus vs. continuous) and positioning of feeding
syringes during enteral feedings (vertical vs. horizontal) will also impact the delivery of
macronutrients, particularly fat.
In an attempt to facilitate stronger fortification strategies for our NICU’s, Mothers’ Milk Bank
Northeast will provide each facility with a Milk Batch Analysis Report (MBAR) with each
shipment. The MBAR will provide the HMA results for fat, carbohydrates, true protein, crude
protein, total solids, and energy counts. We will continue to make it our priority to send our
highest fat and protein count batches to NICU’s at no additional cost.Our focus will be to follow
the new HMBANA (Human Milk Bank Association of North America Guidelines) that encourage
the “pooling” or combining of three or more donors in each batch and to move away from an
emphasis on calories and towards an emphasis on fat and protein. As a reference milk batch
analysis reports (MBAR’s) may look similar to the model below.
Standard Milk: 3.2-4.2 g/dL total fat, .9-1.2g/dl crude protein (19-21 k cal)
Protein Plus Milk : 3.2-4.2 g/dl total fat, 1.3 g/dl crude protein (19-21 k cal)
Energy Plus Milk: >4.3 g/dl total fat, .9-1.2 g/dl crude protein ( >22 k cal)
Community Milk: 2.2 g/dl total fat, .8 g/dl crude protein (16-18 k cal)
Reduced Fat Milk: <1 g/dl total fat, >.9 g/dl crude protein (16-18 k cal)
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The move away from calorie-named based products is a reflection of the accuracy of the milk
analyzers that are most efficient at measuring fat and crude protein, and not precise enough to
distinguish between 19 and 20 kcal/oz milk. On these reports a range for calories will be
provided with the focus on the fat and crude protein. It is critical to note that the MIRIS HMA
results reported by Mothers Milk Bank should not be the sole basis for the management of the
infant’s nutrition care. The HMA device provides the range of energy and macronutrients in
PDHM but cannot determine the bioavailability of any nutrient. The results of human milk
analysis will not alone predict infant growth. Multidisciplinary monitoring of the infant’s weight,
growth, and labs will remain the gold standard for assessing the infant’s nutrition needs.
Please feel free to reach out with any questions via email at info@milkbankne.org
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Appendix B

Statement on Analysis of Donor Human Milk
Staff Medical Alerts
We often answer questions from health care providers about our detailed and
evidence-based safety protocols, including donor screening modeled after
blood banking and milk storage, and testing and pasteurization techniques
compliant with FDA food preparation regulations and the Human Milk Banking
Association of North America (HMBANA).
Recently, we have received a number of queries about milk analysis. Milk
analysis is a relatively new addition to the tools available to neonatologists
and NICUs. As a new technology, it takes time to conduct research and to
determine best practices.
The Mothers’ Milk Bank Northeast (MMBNE) Medical and Research Advisory
Boards have considered this issue carefully. The state of the current
technology now supports the decision to analyze our donor milk for nutritional
content. We and other colleagues in the medical, research, and milk banking
community are energized about the new evidence on the accuracy and clinical
utility of the analyzers now available and in use.

In 2018 the FDA permitted (for the first time) marketing of the infrared
spectroscopy system (MIRIS Human Milk Analyzer) to analyze human milk
and determine the concentrations of fat, carbohydrate, protein, solids, and
energy. “Knowing the macronutrient content of the breast milk may help
the health care team and parents make informed decisions on how to fortify
the breast milk based on the individual needs of the infant.” (“FDA Permits
Marketing of a Diagnostic Test to Aid in Measuring Nutrients in Breast
Milk,” 2018)
Neonatal Intensive Care Units (NICUs) want analysis of milk to account for
individual variation when fortifying donor human milk, the Miris Human Milk
Analyzer measures that individual variation accurately. HMBANA guidelines
require milk banks to pool milk from multiple donors to achieve a good mix, an
average of the components of mothers’ milk. This reduces the variation
among batches of pasteurized donor milk. This is designed to make each
batch of donor milk as close to the literature values for mature milk (milk
produced from one month parturition onward) as is feasible.
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MMBNE’s new policy (in response to the FDA regulations) is that it is
efficacious to provide representative (averaged) milk while providing additional
nutritional information obtained through the use of the MIRIS Human Milk
Analyzer. The nutritional content (energy, fat, protein, carbohydrate values) of
human milk changes over time; fortification without knowledge of
macronutrient breakdown has the potential to miss nutritional targets for
infants at risk. The Miris HMA can measure these components effectively,
enabling adapted, targeted fortification as appropriate.
It is our belief, inspired by science and research (and supported by the FDA),
that this approach to analysis of donor human milk stands to reduce the
variability in nutritional intake, providing the greatest opportunities for
sustained physical growth for infants in need.

FDA permits marketing of a diagnostic test to aid in measuring nutrients in
breast milk. (2018). Case Medical Research. https://doi.org/10.31525/fda2ucm629089.htm
.
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Appendix C

Table 1
Proposed Budget
The Incorporation of a Human Milk Analyzer into a Milk Bank, With the Creation of a Template
to Streamline the Process for Other Milk Banks.

Resources

Estimated
Expense

Actual Expense

MIRIS Human Milk Analyzer

$50,000

$50,000

Annual expense for HMA supplies/ disposables

$7,000

$6,437

Principal investigator, author of template. Estimated
100 hours

volunteer

$0

Expense of laboratory staff training

$0 Incorporated
in cost of HMA

$0 Incorporated
in cost of
analyzer

Marketing (Communication to hospitals via letters,
emails and web updates) 20 hours of time divided by
three people to create marketing materials to roll out the
program, at an average of 30$ an hour.

20 hours x $30/
hour= $600

$600

Printer paper and paper for labeling bottles annually

$200

$200

Platinum Service Contract with MIRIS Labs

$500 annually

$500 annually

Total

$58,300

$57,737
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Appendix D
Theory Logic Model

Program:

The Incorporation of a Human Milk Analyzer (HMA), and the Development of a Template for the Processing of
Pasteurized Donor Human Milk (PDHM) in a Milk Bank

Situation: PDHM has traditionally been distributed to NICU's, from milk banks without maacronutrient content breakdown as

part of the sample. The FDA has recently approved the use of the MIRIS Human Milk Analyzer (HMA) for
identification of that content. This project seeks to chronicle one milk banks journey of incorporation and establish a
template for other milk banks to use, as they incorporate human milk analysis fro a seamless and successful
transition.
Inputs

Funding for Human
Milk Analyzer

Time, education
and experience of
multidiscipilinary
team

Outputs
Activities

Participation

Short

Incorporate analysis
of PDHM, evaluate
data and results of
MBAR reports

NICU's are receptive
to the change
process

PDHM will be
strategically pooled and
analyzed for
macronutrients.

Inform hospitals
using PDHM of the
change process re
HMA via letter

Organizational need
and support

Framework for
template
Incorporating a
HMA into a Milk
Bank

Hospitals receiving
PDHM provide
feedback to milk
bank throughout
experience

Conduct reviews of
the process as it
evolves and pilot the
change, if needed

Chronicle the
process of
incorporation, for the
development of a
template

Template will make
incorporation of HMA
standardized for milk
banks intiating
change

Assumptions= The program resources are adequate and available to
support the incorporation of a HMA into practice. The HMA will provide
macronutrient content of PDHMto NICU's through milk batch analysis
reports. A template will provide guidance, resources and support in
accordance with HMBANA standards to other milk banks.

Move away from calorie
name based products,
as per NUTS
recommendations
Increase precision of
delivery of PDHM, focus
on fat and crude protein

Offer template to other
milk banks and MIRIS
labs to distribute with
their analyzers.

Outcomes
Medium
Incorporate HMA
information with
multidisciplinary
monitoring of infants
growth & lab values.
Facilitate an
educational platform
for the use of HMA
PDHM, increase
awareness of value
Guidelines and
templates will be
adopted & embraced
at various milk
banks, & supported/
HMBANA

Long

Through the use of a
structered template
for HMA, babies will
receive targeted milk
based on their
gestational needs
and the
macronutrient
content of PDHM.
Neonatologists,
pediatricians, nurses
and dieticians will
feel confident the
process of HMA of
PDHM.

External Factors = Bacillus infection rates (bacterial contamination of
milk) are propogated when we try to increase the number of donors in a
pool for donation. Pooling is ideal and essential , as it increases the
macronutrient fortification value of the product. Combining three or more
donors is recomended when using HMA.
Rev. 7/09
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Appendix E
Template for the Incorporation of a Human Milk Analyzer into Your Milk Bank
Procedures for Milk Analysis in your Milk Bank
The intent of this template is to translate evidence acquired to guide safe and effective nursing
care across a variety of settings. Through this process, I have been developing a procedural
template that other milk banks, and NICUs can use to facilitate an easy transition from theory to
practice. The Human Milk Analyzer (HMA) is currently the only FDA approved modality (of
any sort) to measure energy, fat, carbohydrate, and protein content in human milk. It does so
within minutes, using a small volume of supply. These measurements of pasteurized donor
human milk (PDHM) are conducted in an effort to provide targeted, individualized nutrition for
babies due to the high macronutrient variability in human milk throughout the lactation period
(nutrient content of full term donor milk is different than that of preemie donor milk) This
process assures that the neediest babies receive the densest milk available to them. The template
chronicles the journey, change process, and experiences of this idea from the concept
introduction, staff education (in servicing), incorporation, launch and continuance.

7. Introduction
The current trend in milk banking includes the incorporation of pasteurized donor human milk
analysis to further understand macronutrient content (As of May 2021, 6 out of 30 nonprofit milk
banks in North America are using a HMA. There are milk banks using other types of analyzers
that have not been FDA approved specifically for human milk analysis). The intent is to translate
evidence acquired to guide safe and effective targeted medical and nursing care across a variety
of settings.
Using the Human Milk Analyzer through this process will facilitate the most targeted nutrition
for infants (Ray, 2014).
“The U.S. Food and Drug Administration permitted marketing of the Human Milk Analyzer, a
new diagnostic test to aid healthcare professionals in measuring nutrients in breast milk,
including the concentration of fat, carbohydrate, protein, total solids, and energy. The test
provides healthcare professionals with a new tool to aid in the nutritional management of
newborns and young infants at risk for growth failure due to prematurity or other medical
conditions.” (“FDA Permits Marketing of a Diagnostic Test to Aid in Measuring Nutrients in
Breast Milk,”2018) In 2018 the FDA provided approval for use in CLIA labs only, and in 2019
the use of MIRIS HMA was approved universally.
Why collect and analyze human milk? Breast milk is the ideal nutrition source and the gold
standard feeding method for infants. Breast milk significantly reduces premature babies’ chances
of developing NEC (necrotizing enterocolitis is a disease associated with prematurity that affects
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the lining of the small intestine. The intestine becomes damaged, necrotic and dies resulting in
surgery. Infants who are exclusively formula fed are at higher risk for NEC.) Human milk,
including donor milk, also offers gastrointestinal protection, strengthens immunity, decreases the
likelihood of asthma, allergies, ear infections, obesity, and respiratory ailments. Some mothers
are unable to breastfeed their own babies due to a multitude of medical conditions (breast
surgery, breast cancer, thyroid disease, PCOS, hypoplasia, medication contraindication,
complicated birth/ postpartum hemorrhage, or retained placenta). For these mothers and babies,
donor milk is a viable option. The use of a milk analyzer when evaluating and processing human
milk can provide better insight into the macronutrient content of the donors’ samples. This
process can allow for a more targeted pooling of the samples.

II. Goal
The state of the current technology now supports the decision to analyze donor milk for
nutritional content.
The outcome goal post-implementation includes targeted milk for babies in need, resulting in
improved growth rates.
“We and other colleagues in the medical, research, and milk banking community are energized
about the new evidence on the accuracy and clinical utility of the analyzers now available and in
use.”(About Us • Mothers’ Milk Bank Northeast, n.d.)
III. Analyzer Use
What is the need you have identified for analysis of donor human milk? Why do you want to
better understand PDHM nutritional content?
Which hospital neonatal intensive care units are requesting this service? Why do they want it?
Understand the current state of technology and research that supports macronutrient analysis of
human milk. What are the drawbacks?
Consult with your milk bank’s medical and research advisory boards for their perspectives.
Seek consensus among the Board of Directors, employees, and hospitals receiving donor milk
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VI. Develop a Budget
The budgeting portion is critical to ensure that adequate resources are set aside prior to project
implementation.
Through strategic planning, effective allocation, and earmarking, the milk bank can develop a
successful budget to guide their non-profit milk bank to the forefront of change and progress in
this industry.
Allocating funds for the capital purchase of the analyzer can come from the milk bank (or
hospital) revenue, fund raising, or application for acceptance of a non-profit grant.

Resources

Estimated
Expense

Human Milk Analyzer

$50,000

Annual expense for HMA supplies/ disposables

$7,000

Extras

Expense of laboratory staff training

$0
Incorporated
in cost of
HMA by
MIRIS Labs

Marketing (Communication to hospitals via letters, emails and
web updates) 20 hours of time

20 hours x
approximate
-ly $30/
hour= $600

Printer paper and paper for labeling bottles annually

$200

Platinum Service Contract with MIRIS Labs

$500
annually

Actual
Expense
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$58,300
V. Develop a Timeline
Once the team has committed to the investment in the HMA, develop a project timeline with a
roll out in approximately 6-10 months. Decide where analyzer fits in other strategic and
operational priorities.
Leave time for staff education, and troubleshooting associated with learning to use new
equipment, increased donor pooling and potential rise in bacillus rates.

VI. Develop a Marketing Plan
Marketing a project in the confines of the milk bank hospital dynamics is much less complex
than marketing a product in the business world to consumers. Buy in already exists based on the
nature of the established, trusting relationships, and the mutual goal of delivering quality
healthcare.
The Human Milk Analyzer project is research based, with an educational tool designed to
improve the process of allocation of human milk based on its macronutrient content and the
nutritional needs of NICU babies.
Marketing includes the preparation of an informative letter notifying the participating hospitals’
NICUs of the change process, the inclusion of estimated milk batch analysis reports (or specified
bottle labels) with each batch of donor milk delivered, and finally an update to the milk bank
website informing the public about the analyzer. ( letters attached)
The estimated financials of the marketing plan include communication with hospitals via letters,
emails and web updates, 20 hours of time divided by three people to create materials to roll out
the program, at an average of $30 an hour for twenty hours, or $600. The key stakeholders
include; the milk bank, the participating hospitals, the recipients of the donor milk (neonates),
parents of premature babies and the breastfeeding community at large.
VII. Training
MIRIS has built extensive knowhow and expertise on coaching their customers in setting up the
best solutions for their specific needs.
MIRIS assumes full responsibility for staff and laboratory training tailored to your milk bank
needs.
Online demonstrations in the Miris Studio™ give you the opportunity to discover everything
from set up, walk-through the different sequences in the daily use of Miris HMA™ and the
process of human milk analysis.
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VIII. Available Supporting Resources
Included as a supplement to this template, for your reference, exists an Annotated Bibliography,
SWOT Analysis, Theory Logic Model and Risk Management Profile. (will provide upon
request)
IX. Access to Experts
Who are the experts in your organization (neonatologists, dieticians, scientists, pediatricians,
nurses, lactation consultants, feeding specialists) or on your Board of Directors? Who are the
hospital experts in the NICUs’ receiving your donor milk?
Access the knowledge of your experts to help the organization achieve implementation and
sustainability.
Provide an online platform for accessing experts via zoom, email, chat group, Facebook page, etc
to improve and fortify the human milk analysis experience. Tap into their knowledge throughout
the journey of milk analysis and after the roll-out is complete.
Take advantage of the experiences of other milk banks that have incorporated an analyzer in
their practice. Set up meetings, access protocols and tap into the knowledge of those using the
MIRIS HMA.
X. Evaluate and Practice HMA on Small Samples
In an effort to increase laboratory staff proficiency and productivity, test small samples as often
as possible over a sufficient period of time prior to the official roll-out to ensure a successful
transition to milk analysis, and to implement efficiencies and improvements before roll out.
Conscious efforts should be made during this process to increase the number of donors per pool
(recommended 3-5) in an effort to more richly fortify the milk. Bacillus rates should be
monitored continually through this process as there is an increased propensity with increase in
number of donors in a pool. (Troubleshooting this process can delay the roll-out timeline.)
Through the incorporation of modified, targeted educational plans to donors (pump cleaning,
milk storage), and through the consultation of milk experts and product line experts additional
(specified) modifications can be made with regard to milk processing, resulting in improvements
in bacterial rates.
Evaluate and modify (as needed for your bank) the excel spreadsheet that comes with the MIRIS
HMA. This spreadsheet will be directly connected to the milk batch analysis reports and bottle
labels you attach to the donor milk, so ensure that the spreadsheet is appropriate to your needs.
XI. Roll-Out
Develop a formal launch plan that includes; schedule, milestones, alignment and communication
with the hospital.
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Make certain that all components are aligned prior to launch; marketing, customer service,
clinical experts, administration, laboratory staff, etc.
Establish a plan to track progress of the use of human milk analyzer once received by NICUs
Seek feedback on an established schedule from NICUs.
Ensure the oversight and ongoing evaluation-processes are rigorous, regular, compliant with
regulations and standards and documented.
Follow carefully the manufacturers recommendations and the Human Milk Bank Association of
North America (HMBANA) standards and requirements regarding upkeep, calibration and
validation of the HMA.
The greatest opportunities for this project are connected to the unique occasion to improve the
quality and measurability of PDHM, in response to new FDA guidelines. Through macronutrient
analysis, NICUs and postpartum units will have the fortuitous opportunity to provide targeted,
fortified nutrition as a result of this machine and its incorporation into practice. Using the MIRIS
HMA can enhance growth rates for babies improving their transition out of the hospital to home.
This project has the opportunity to dispute the claim that “babies don’t thrive on donor milk”
based on clear, factual data.
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Appendix F
Follow up Survey

Follow Up Survey, Post Template Implementation
Procedures for Milk Analysis at a Milk Bank

1.How likely is it that you would recommend the use of this template to another milk
bank?
a.
b.
c.
d.
e.

Extremely likely
Very likely
Likely
Not likely
Definitely not

2. Overall how would you rate this template?
a.
b.
c.
d.
e.

Excellent
Very good
Good
Fair
Poor

3. What do you like about this template?

What did you dislike about this template?
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5. How organized was this template?
a.
b.
c.
d.
e.

Extremely organized
Very organized
Somewhat organized
Not so organized
Not at all organized

6. How helpful was the template?
a.
b.
c.
d.
e.

Extremely helpful
Very helpful
Somewhat helpful
Not so helpful]
Not at all helpful

7. Is there anything else you would like to share about the template?
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Appendix G
Follow Up Survey, Post Implementation
Procedures for Milk Analysis at a Milk Bank
The composition of human milk (donor or mother’s own milk) is quite variable and having a
baseline nutrient content to aid in the fortification of milk for infants is ideal. The variability of
human milk macronutrients is related to many factors. The state of the current technology
supports the decision to analyze our donor milk for nutritional content. Please take some time to
complete this survey and let us know how your hospital is embracing PDHM Analysis.
1. When did your facility start using PDHM that has been analyzed for macronutrient
content?

2. How was this change process received by health care professionals?

3. Please describe your hospital-based protocol for allocation of milk that has been
analyzed. Is there a direct connection to the MBAR reports?

4. Is there a conversation with parents about the use of PDHM that has been analyzed?

5. How do the bottle labels and milk batch analysis reports influence allocation?

6. Is there anything we can do to make this process easier for you?

7. How are you tracking the outcomes from use of analyzed milk? What have you found
thus far?
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